Parliamentary QA
DENGUE VACCINES SUBMITTED TO HEALTH SCIENCES AUTHORITY FOR CONSIDERATION FOR REGISTRATION
10 January 2024
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
NOTICE PAPER NO. 2464
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR THE SITTING OF PARLIAMENT ON OR AFTER 10 JANUARY 2024
Name and Constituency of Member of Parliament
Ms Sylvia Lim
MP for Aljunied GRC
Question No. 5330
To ask the Minister for Health (a) which of the dengue vaccine candidates submitted to the Health Sciences Authority (HSA) are under consideration for registration; and (b) what is the status of Takeda’s TAK-003 application to the HSA for registration as a dengue vaccine.
Answer
1 Takeda has withdrawn the application to register its dengue vaccine in Singapore following a review by the Health Sciences Authority (HSA) on its submitted scientific data. We note that the vaccine’s application was also withdrawn in the United States. At this point in time, there is no other application for registration of dengue vaccine to HSA. The Ministry of Health will continue to monitor the development of dengue vaccines as part of a multi-pronged approach to dengue control in Singapore.